Zinc supplementation and the effects on metabolic status in gestational diabetes: A randomized, double-blind, placebo-controlled trial

被引:44
|
作者
Karamali, Maryam [1 ,2 ]
Heidarzadeh, Zahra [3 ]
Seifati, Seyed Morteza [3 ]
Samimi, Mansooreh [4 ]
Tabassi, Zohreh [4 ]
Hajijafari, Mohammad [5 ]
Asemi, Zatollah [5 ]
Esmaillzadeh, Ahmad [6 ,7 ]
机构
[1] Arak Univ Med Sci, Dept Gynecol & Obstet, Sch Med, Arak, Iran
[2] Iran Univ Med Sci, Dept Gynecol & Obstet, Sch Med, Tehran, Iran
[3] Islamic Azad Univ, Dept Biol, Ashkezar, Iran
[4] Kashan Univ Med Sci, Dept Gynecol & Obstet, Sch Med, Kashan, Iran
[5] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran
[6] Isfahan Univ Med Sci, Food Secur Res Ctr, Esfahan, Iran
[7] Isfahan Univ Med Sci, Dept Community Nutr, Sch Nutr & Food Sci, Esfahan, Iran
关键词
Zinc; Supplementation; Insulin metabolism; Lipid concentrations; Gestational diabetes; OXIDATIVE STRESS; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; HYPERTENSION; LIPOPROTEINS; INFLAMMATION; RESISTANCE; PREGNANCY; CHILDREN;
D O I
10.1016/j.jdiacomp.2015.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To the best of our knowledge, no reports are available indicating the effects of zinc supplementation on metabolic status in women with gestational diabetes (GDM). This study was designed to determine the effects of zinc supplementation on glucose homeostasis parameters and lipid concentrations in GDM women. Methods: This randomized, double-blind, placebo-controlled trial was performed among 58 women diagnosed with GDM, primigravida and aged 18-40 years old. Patients were randomly divided into two groups to receive 233 mg zinc gluconate (containing 30 mg zinc) supplements (n = 29) or placebo (n = 29) per day for 6 weeks. Fasting blood samples were taken at the beginning and end of the trial to quantify glucose, insulin and lipid concentrations. Results: Patients who received zinc supplements had significantly higher serum zinc concentrations (+ 6.9 13.2 vs. -1.5 +/- 16.5 mg/dL, P = 0.03) than those received the placebo. In addition, zinc-supplemented patients had reduced fasting plasma glucose (FPG) (-6.6 +/- 11.2 vs. + 0.6 +/- 6.7 mg/dL, P = 0.005), serum insulin levels (-1.3 +/- 6.6 vs. + 6.6 +/- 12.2 mu IU/mL, P = 0.003), homeostasis model of assessment-insulin resistance (HOMA-IR) (-0.5 +/- 1.6 vs. +1.5 +/- 2.7, P = 0.001), homeostatic model assessment-Beta cell function (HOMA-B) (-0.7 +/- 25.0 vs. + 26.5 +/- 49.5, P = 0.01) and increased quantitative insulin sensitivity check index (QUICKI) ( + 0.01 0.01 vs. -0.01 +/- 0.02, P = 0.004) compared with the placebo. Additionally, significant differences in serum triglycerides (+ 13.6 +/- 61.4 vs. +45.9 +/- 36.5 mg/dL, P = 0.01) and VLDL-cholesterol concentrations (+2.7 +/- 12.3 vs. +9.2 +/- 7.3 mg/dL, P = 0.01) were observed following the administration of zinc supplements compared with the placebo. We did not observe any significant effects of taking zinc supplements on other lipid profiles. Conclusions: Taken together, 30 mg zinc supplementation per day for 6 weeks among GDM women had beneficial effects on metabolic profiles. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:1314 / 1319
页数:6
相关论文
共 50 条
  • [21] Effects of synbiotic supplementation on the components of metabolic syndrome in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
    Basafa-Roodi, Poorya
    Jazayeri, Shima
    Hadi, Fatemeh
    Paghaleh, Somaye Jamali
    Khosravi-darani, Kianush
    Malakouti, Seyed Kazem
    BMC PSYCHIATRY, 2024, 24 (01)
  • [22] Pterostilbene on Metabolic Parameters: A Randomized, Double-Blind, and Placebo-Controlled Trial
    Riche, Daniel M.
    Riche, Krista D.
    Blackshear, Chad T.
    McEwen, Corey L.
    Sherman, Justin J.
    Wofford, Marion R.
    Griswold, Michael E.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [23] Magnesium Supplementation and the Effects on Wound Healing and Metabolic Status in Patients with Diabetic Foot Ulcer: a Randomized, Double-Blind, Placebo-Controlled Trial
    Reza Razzaghi
    Farangis Pidar
    Mansooreh Momen-Heravi
    Fereshteh Bahmani
    Hossein Akbari
    Zatollah Asemi
    Biological Trace Element Research, 2018, 181 : 207 - 215
  • [24] Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial
    MacKenzie, Todd
    Comi, Richard
    Sluss, Patrick
    Keisari, Ronit
    Manwar, Simone
    Kim, Janice
    Larson, Robin
    Baron, John A.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (12): : 1694 - 1698
  • [25] The effects of wheat germ supplementation on metabolic profile in patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial
    Mohammadi, Hamed
    Karimifar, Mozhgan
    Heidari, Zahra
    Zare, Maryam
    Amani, Reza
    PHYTOTHERAPY RESEARCH, 2020, 34 (04) : 879 - 885
  • [26] Fluoxetine for depression in diabetes - A randomized double-blind placebo-controlled trial
    Lustman, PJ
    Freedland, KE
    Griffith, LS
    Clouse, RE
    DIABETES CARE, 2000, 23 (05) : 618 - 623
  • [27] Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus - A randomized, double-blind, placebo-controlled trial
    Maggs, DG
    Buchanan, TA
    Burant, CF
    Cline, G
    Gumbiner, B
    Hsueh, WA
    Inzucchi, S
    Kelley, D
    Nolan, J
    Olefsky, JM
    Polonsky, KS
    Silver, D
    Valiquett, TR
    Shulman, GI
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (03) : 176 - 185
  • [28] Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial
    Fung, Ellen B.
    Kwiatkowski, Janet L.
    Huang, James N.
    Gildengorin, Ginny
    King, Janet C.
    Vichinsky, Elliott P.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2013, 98 (04): : 960 - 971
  • [29] CHOLECALCIFEROL SUPPLEMENTATION AND INFLAMMATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Seibert, Eric
    Ulrich, Christof
    Trojanowicz, Bogusz
    Lehmann, Ulrike
    Dierkes, Jutta
    Stangl, Gabriele I.
    Girndt, Matthias
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [30] An Expression of Concern from the AJCN Editorial Office about: Magnesium supplementation affects metabolic status and pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial
    Asemi, Zatollah
    Karamali, Maryam
    Jamilian, Mehri
    Foroozanfard, Fatemeh
    Bahmani, Fereshteh
    Heidarzadeh, Zahra
    Benisi-Kohansal, Sanaz
    Surkan, Pamela J.
    Esmaillzadeh, Ahmad
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2020, 112 (05): : 1407 - 1407